BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21109450)

  • 1. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer.
    Ness RB; Dodge RC; Edwards RP; Baker JA; Moysich KB
    Ann Epidemiol; 2011 Mar; 21(3):188-96. PubMed ID: 21109450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.
    Dorjgochoo T; Shu XO; Li HL; Qian HZ; Yang G; Cai H; Gao YT; Zheng W
    Int J Cancer; 2009 May; 124(10):2442-9. PubMed ID: 19170208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is there a place for tubal ligation in modern contraception?].
    von Mering R; Merki GS; Keller PJ
    Gynakol Geburtshilfliche Rundsch; 2003 Jan; 43(1):25-30. PubMed ID: 12499754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and risks of contraception.
    Droegemueller W; Bressler R
    Annu Rev Med; 1980; 31():329-43. PubMed ID: 6994615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer.
    Ness RB; Grisso JA; Vergona R; Klapper J; Morgan M; Wheeler JE;
    Epidemiology; 2001 May; 12(3):307-12. PubMed ID: 11337604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefits and risks of alternative methods of fertility control in the United States.
    Kawachi I; Colditz GA; Hankinson S
    Contraception; 1994 Jul; 50(1):1-16. PubMed ID: 7924318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
    Oddens BJ
    Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraception and ectopic pregnancy risk.
    Franks AL; Beral V; Cates W; Hogue CJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1120-3. PubMed ID: 2220914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of family planning clients in Bangladesh.
    Swenson I; Khan AR
    Int J Fertil; 1983; 28(3):149-55. PubMed ID: 6140233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraceptive Use and the Risk of Ectopic Pregnancy: A Multi-Center Case-Control Study.
    Li C; Zhao WH; Meng CX; Ping H; Qin GJ; Cao SJ; Xi X; Zhu Q; Li XC; Zhang J
    PLoS One; 2014; 9(12):e115031. PubMed ID: 25493939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
    BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contraception and tubal sterility of infective origin].
    Gayer ML; Henry-Suchet J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):155-64. PubMed ID: 2324437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive use before tubal sterilization.
    Grubb GS; Rubin GL; Layde PM
    J Reprod Med; 1985 Apr; 30(4):345-50. PubMed ID: 4009552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.
    Fang NZ; Westhoff CL
    Am J Obstet Gynecol; 2022 Sep; 227(3):477.e1-477.e7. PubMed ID: 35569515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk.
    Holt VL; Cushing-Haugen KL; Daling JR
    Obstet Gynecol; 2003 Aug; 102(2):252-8. PubMed ID: 12907096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.